Stock watch - Borland
Despite industry surprise at Borland's acquisition of Visigenics, the reaction from Wall Street was not favourable as share prices fell $1.50 on the announcement of the deal (see news story, page 28).
Highlights
Despite industry surprise at Borland's acquisition of Visigenics, the reaction from Wall Street was not favourable as share prices fell $1.50 on the announcement of the deal (see news story, page 28).
Highlights